Profusa (PFSA) Faces Stiff Competition in Surgical Instruments Industry

Profusa lags rivals in key metrics like revenue, earnings, and institutional ownership

Published on Mar. 10, 2026

Got story updates? Submit your updates here. ›

Profusa (NASDAQ:PFSA) is one of 27 publicly-traded companies in the 'Surgical, Medical, And Dental Instruments And Supplies' industry, but it faces significant competition from its rivals. A comparison of Profusa and its competitors shows that Profusa trails in areas like revenue, earnings per share, institutional ownership, and stock price volatility.

Why it matters

The surgical instruments industry is highly competitive, and Profusa's weaker performance compared to its peers could make it challenging for the company to gain market share and remain profitable long-term. Investors will be closely watching how Profusa fares against its better-performing rivals.

The details

Profusa's net margins, return on equity, and return on assets all lag behind the industry averages. The company also has lower institutional and insider ownership than its competitors. Analysts believe Profusa's rivals have stronger consensus ratings and greater potential upside. While Profusa's stock is less volatile than the industry average, its rivals generate higher revenue and earnings per share.

  • Profusa (NASDAQ:PFSA) is a publicly-traded company.

The players

Profusa

A publicly-traded company in the 'Surgical, Medical, And Dental Instruments And Supplies' industry.

NorthView Acquisition Corporation

A subsidiary of NorthView Sponsor I, LLC that intends to merge with or acquire a healthcare-focused business.

Got photos? Submit your photos here. ›

The takeaway

Profusa faces an uphill battle against its better-performing rivals in the highly competitive surgical instruments industry. The company will need to find ways to improve its financial metrics and operational efficiency to remain competitive and attractive to investors.